Gene Mutation and Endometrial Cancer Greensboro NC

A genetic marker for aggressive endometrial cancer has been identified by U.S. researchers, who said their finding could lead to more targeted and risk-appropriate treatments. The researchers, from the Washington University School of Medicine in St. Louis, found that genetic mutation of the ATR gene in tumors boosts the risk of cancer recurrence and death in women#r3 with a highly aggressive form of the disease known as endometrioid endometrial cancer.

Dr. James G Crawford
(336) 419-1329
107 N Murrow Blvd
Greensboro, NC

Data Provided by:
David M. Bowers
(336) 275-0919
300 W. Northwood Street
Greensboro, NC
Specialties
Cosmetic Surgery
Insurance
Medicare Accepted: No
Workmens Comp Accepted: No
Accepts Uninsured Patients: No
Emergency Care: No


Data Provided by:
Healing Hands Chiropractic
(336) 303-8980
1915 Lendew Street
Greensboro, NC

Data Provided by:
Crawford Chiropractic Center
(336) 450-2614
1109 Summit Ave
Greensboro, NC

Data Provided by:
Chiropractic Spine & Sports
(336) 419-1405
2300 W. Meadowview Rd.
Greensboro, NC

Data Provided by:
Daniel F Murphy, MD
(336) 375-2300
1130 N Church St
Greensboro, NC
Business
Murphy & Wainer Orthopaedics
Specialties
Orthopedics

Data Provided by:
Happy Tails Veterinary Emergency Clinic
(336) 288-2688
2936 Battleground Ave
Greensboro, NC

Data Provided by:
Stephen A South, MD
(336) 621-8911
2703 Henry St
Greensboro, NC
Business
Guilford Medical Associates PA
Specialties
Endocrinology, Diabetes & Metabolism

Data Provided by:
Lawndale Veterinary Hospital
(336) 288-3233
4314 Lawndale Dr
Greensboro, NC

Data Provided by:
Greensboro Veterinary Hospital
(336) 299-5431
3741 High Point Rd
Greensboro, NC

Data Provided by:
Data Provided by:

Gene Mutation and Endometrial Cancer

Provided By:

WEDNESDAY, May 27 (HealthDay News) -- A genetic marker for aggressive endometrial cancer has been identified by U.S. researchers, who said their finding could lead to more targeted and risk-appropriate treatments.

The researchers, from the Washington University School of Medicine in St. Louis, found that genetic mutation of the ATR gene in tumors boosts the risk of cancer recurrence and death in women with a highly aggressive form of the disease known as endometrioid endometrial cancer.

The ATR gene directs cellular responses to DNA damage, the researchers noted.

"Women whose endometrial cancers have an ATR mutation have more than four times the risk of having their cancer return," study author Dr. Israel Zighelboim, a gynecologic oncologist, said in a news release from the university. "This and similar tumor biomarkers could potentially identify those patients most in danger of recurrence and guide the development of treatments aimed at these more aggressive tumors."

ATR mutations were found in about 5 percent of the 248 endometrioid endometrial tumor samples analyzed by the researchers. Women with ATR mutations were 4.29 times more likely to have the cancer recur after treatment and 3.88 times more likely to die.

The study appears online in the Journal of Clinical Oncology.

Zighelboim and his research colleagues plan to see if the prognostic value of ATR mutations can be confirmed in a larger group of women and to investigate the association between ATR mutations and treatment response after cancer recurrence.

More information

The American Cancer Society has more about endometrial cancer.

SOURCE: Washington University School of Medicine in St. Louis, news release, May 26, 2009

Copyright © 2009 ScoutNews, LLC. All rights reserved.

Read Article at HealthDay.com